Kronos Bio Inc expected to post a loss of 28 cents a share - Earnings Preview

Kronos Bio

08/11/2024 15:49

* Kronos Bio Inc  KRON.OQ   KRON.O  is expected to show a
rise in
quarterly revenue when it reports  results on November 11
(estimated) for the period ending September 30 2024
    * The San Mateo California-based  company is expected to
report a
129.0% increase in revenue to $2.1 million from $917 thousand a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Kronos Bio Inc is for a
loss
of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Kronos Bio
Inc is
$4.13​, above​ its last closing price of $0.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.33       -0.34      -0.27     Beat    20
 Mar. 31 2024  -0.42       -0.42      -0.29     Beat    31.4
 Dec. 31 2023  -0.53       -0.52      -0.34     Beat    35.2​
 Sep. 30 2023  -0.45       -0.51      -0.54     Missed  -5.4
 ​​Jun.        -0.43       -0.46      -0.52     Missed  -13
 30 2023                                                
 Mar. 31 2023  -0.27       -0.44      -0.46     Missed  -3.4​
 Dec. 31 2022  -0.48       -0.59      -0.56     Beat    4.4
 Sep. 30 2022  -0.65       -0.65      -0.57     Beat    12.6
 This summary was machine generated November 8 at 15:49 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)